Status:
COMPLETED
Anxiety, Depression, and Quality of Life in Patients With Fibromyalgia During the Coronavirus Disease 2019 Pandemic
Lead Sponsor:
Ege University
Conditions:
Fibromyalgia
Coronavirus Disease 2019 Pandemic
Eligibility:
All Genders
18+ years
Brief Summary
Fibromyalgia patients and controls living in the same household will be evaluated for levels of resilience, covid-19 related anxiety, coronavirus disease 2019 related obsession, quality of life and pa...
Detailed Description
Fibromyalgia is a generalized pain condition that is accompanied by sleep disturbances, anxiety, depression and somatic symptoms. During Coronavirus disease 2019 pandemic, fibromyalgia patients as wel...
Eligibility Criteria
Inclusion
- Having a diagnosis of fibromyalgia according to the American college of rheumatology 2016 classification criteria
- Older than 18 years of age
Exclusion
- Illiteracy
- A history of coronavirus disease 2019 infection in the last month
- Change in medication to treat fibromyalgia in the last 3 months
- Living alone (lack of a control subject)
- Severe neurological or psychiatric disorder that might hinder subjects' ability to answer the study questions
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2022
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT05410808
Start Date
December 1 2021
End Date
July 15 2022
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ege University School of Medicine
Bornova, İzmir, Turkey (Türkiye), 35100